Author

A. Ueno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

A. Ainai· 1 shared H. Fukaki· 1 shared H. Hasegawa· 1 shared H. Kato· 1 shared H. Kawasuji· 1 shared H. Tani· 1 shared H. Yamada· 1 shared H. Yonetsuka· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ainai

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Regulation of ROP GTPase cycling between active/inactive states is essential for vegetative organogenesis in Marchantia polymorpha

Y. Sakai, A. Ueno, H. Yonetsuka, T. Goh, H. Kato, Y. Kondo, H. Fukaki, K. Ishizaki

This study investigates the roles of ROP GTPase regulators in organogenesis of Marchantia polymorpha, showing that both GAPs and GEFs are essential for controlling the active/inactive cycle of MpROP.

bioRxiv · Apr 5, 2024 · PreprintPlant Biology

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

T. Hemmi, A. Ainai, T. Hashiguchi, M. Tobiume, T. Kanno, N. Iwata-Yoshikawa, S. Iida, Y. Sato, S. Miyamoto, A. Ueno, K. Sano, S. Saito, N. Shiwa-Sudo, N. Nagata, K. Tamura, , T. Suzuki

This study shows that an intranasal vaccine with CpG ODN2006 induces secretory IgA antibodies against SARS-CoV-2 variants and reduces lung eosinophilic immunopathology compared to subcutaneous vaccination.

bioRxiv · May 24, 2022Microbiology

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

H. Tani, L. Tan, M. Kimura, Y. Yoshida, H. Yamada, S. Fukushi, M. Saijo, H. Kawasuji, A. Ueno, Y. Miyajima, Y. Fukui, I. Sakamaki, Y. Yamamoto, Y. Morinaga

This study evaluates SARS-CoV-2 neutralizing antibodies using a pseudotyped virus assay and compares results with immunofluorescence assay findings.

bioRxiv · Aug 21, 2020Microbiology